Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F. Gil-Lozano M, et al. Among authors: mallo f. Endocrinology. 2014 Jul;155(7):2511-23. doi: 10.1210/en.2013-1718. Epub 2014 Apr 14. Endocrinology. 2014. PMID: 24731096
Orexin A suppresses in vivo GH secretion.
Seoane LM, Tovar SA, Perez D, Mallo F, Lopez M, Señaris R, Casanueva FF, Dieguez C. Seoane LM, et al. Among authors: mallo f. Eur J Endocrinol. 2004 May;150(5):731-6. doi: 10.1530/eje.0.1500731. Eur J Endocrinol. 2004. PMID: 15132732
Exendin-4 potently decreases ghrelin levels in fasting rats.
Pérez-Tilve D, González-Matías L, Alvarez-Crespo M, Leiras R, Tovar S, Diéguez C, Mallo F. Pérez-Tilve D, et al. Among authors: mallo f. Diabetes. 2007 Jan;56(1):143-51. doi: 10.2337/db05-0996. Diabetes. 2007. PMID: 17192476
Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system.
Pérez-Tilve D, González-Matías L, Aulinger BA, Alvarez-Crespo M, Gil-Lozano M, Alvarez E, Andrade-Olivie AM, Tschöp MH, D'Alessio DA, Mallo F. Pérez-Tilve D, et al. Among authors: mallo f. Am J Physiol Endocrinol Metab. 2010 May;298(5):E1088-96. doi: 10.1152/ajpendo.00464.2009. Epub 2010 Mar 2. Am J Physiol Endocrinol Metab. 2010. PMID: 20197503 Free PMC article.
GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans.
Gil-Lozano M, Pérez-Tilve D, Alvarez-Crespo M, Martís A, Fernandez AM, Catalina PA, Gonzalez-Matias LC, Mallo F. Gil-Lozano M, et al. Among authors: mallo f. Endocrinology. 2010 Jun;151(6):2629-40. doi: 10.1210/en.2009-0915. Epub 2010 Apr 2. Endocrinology. 2010. PMID: 20363879 Free article. Clinical Trial.
Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats.
Romaní-Pérez M, Outeiriño-Iglesias V, Moya CM, Santisteban P, González-Matías LC, Vigo E, Mallo F. Romaní-Pérez M, et al. Among authors: mallo f. Endocrinology. 2015 Oct;156(10):3559-69. doi: 10.1210/en.2014-1685. Epub 2015 Jul 21. Endocrinology. 2015. PMID: 26196539
46 results